Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

Details for Australian Patent Application No. 2010323066 (hide)

Owner Genfit

Inventors Darteil, Raphael; Hanf, Remy; Hum, Dean

Agent Davies Collison Cave

Pub. Number AU-A-2010323066

PCT Pub. Number WO2011/064350

Priority 09306146.3 26.11.09 EP

Filing date 26 November 2010

Wipo publication date 3 June 2011

International Classifications

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/064350 Priority application(s): WO2011/064350

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010323068-Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin

2010323059-Exhaust temperature based mode control method for gas turbine and gas turbine